ENO2 and small cell lung carcinoma: Our previous study found that in SCLC, the diagnostic efficacy of eHSP90 as a prognostic evaluation and diagnostic marker is better than NSE, a biomarker of classical SCLC [15]; In this study, we found a positive correlation between eHSP90α and CEA.